Sornchai Looareesuwan

Sornchai Looareesuwan's AcademicInfluence.com Rankings

Philosophy

#6050

World Rank

#9015

Historical Rank

Logic

#3245

World Rank

#4372

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Sornchai Looareesuwan's Degrees

PhD Medical Science Mahidol University
Doctorate Medicine Mahidol University

Why Is Sornchai Looareesuwan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Sornchai Looareesuwan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. (1985) (879)
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number (2004) (772)
Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. (1989) (565)
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study (2000) (541)
Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. (2006) (459)
Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. (1982) (455)
Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. (1996) (395)
Severe hypoglycemia and hyperinsulinemia in falciparum malaria. (1983) (392)
Pharmacokinetics and Pharmacodynamics of Lumefantrine (Benflumetol) in Acute Falciparum Malaria (2000) (339)
Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. (2007) (294)
Malaria Blood Stage Parasites Activate Human Plasmacytoid Dendritic Cells and Murine Dendritic Cells through a Toll-Like Receptor 9-Dependent Pathway1 (2004) (293)
Averting a malaria disaster (1999) (256)
Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross‐sectional survey on the prevalence of fake antimalarials (2004) (249)
An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. (2003) (244)
The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. (1986) (239)
Fake artesunate in southeast Asia (2001) (228)
Ascaris lumbricoides infection is associated with protection from cerebral malaria (2000) (222)
Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria. (1982) (221)
Central role of the spleen in malaria parasite clearance. (2002) (216)
A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. (2001) (205)
Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. (1999) (205)
Parasite multiplication potential and the severity of Falciparum malaria. (2000) (195)
Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. (2000) (195)
Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children (2009) (190)
Dynamic alteration in splenic function during acute falciparum malaria. (1987) (188)
INTESTINAL HELMINTH INFECTIONS ARE ASSOCIATED WITH INCREASED INCIDENCE OF PLASMODIUM FALCIPARUM MALARIA IN THAILAND (2002) (187)
WHO, the Global Fund, and medical malpractice in malaria treatment (2004) (187)
Randomized Comparison of Artemether-Benflumetol and Artesunate-Mefloquine in Treatment of MultidrugResistant Falciparum Malaria (1998) (184)
Therapeutic Responses to Different Antimalarial Drugs in Vivax Malaria (2000) (178)
Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. (1999) (177)
Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. (2001) (174)
QUININE AND SEVERE FALCIPARUM MALARIA IN LATE PREGNANCY (1985) (172)
Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy. (2001) (170)
Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. (1986) (167)
Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. (2000) (165)
Activities of Artesunate and Primaquine against Asexual- and Sexual-Stage Parasites in Falciparum Malaria (2004) (164)
Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria. (2001) (163)
Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. (1999) (154)
Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. (2002) (154)
Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria (1992) (152)
The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. (2004) (149)
Quinine loading dose in cerebral malaria. (1983) (148)
Pathophysiological and prognostic significance of cerebrospinal-fluid lactate in cerebral malaria (1985) (145)
Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1 (2005) (143)
Deployment of Early Diagnosis and Mefloquine- Artesunate Treatment of Falciparum Malaria in Thailand: The Tak Malaria Initiative (2006) (140)
HIGH RATE OF PLASMODIUM VIVAX RELAPSE FOLLOWING TREATMENT OF FALCIPARUM MALARIA IN THAILAND (1987) (138)
A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. (2005) (136)
Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil (2003) (134)
Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria. (1989) (134)
Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. (1994) (134)
Magnetic resonance imaging of the brain in patients with cerebral malaria. (1995) (133)
Extended linkage disequilibrium surrounding the hemoglobin E variant due to malarial selection. (2004) (133)
The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria (2003) (131)
Novel Point Mutations in the Dihydrofolate Reductase Gene of Plasmodium vivax: Evidence for Sequential Selection by Drug Pressure (2003) (130)
Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. (2004) (129)
Reduced levels of transforming growth factor-beta1, interleukin-12 and increased migration inhibitory factor are associated with severe malaria. (2004) (121)
DO PATIENTS WITH CEREBRAL MALARIA HAVE CEREBRAL OEDEMA? A Computed Tomography Study (1983) (116)
Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors. (2003) (116)
In Vivo Assessment of Drug Efficacy against Plasmodium falciparum Malaria: Duration of Follow-Up (2004) (114)
Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients (1987) (114)
Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. (1989) (113)
Severe neurotoxic envenoming by the Malayan krait Bungarus candidus (Linnaeus): response to antivenom and anticholinesterase. (1983) (111)
A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. (2005) (111)
Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. (1985) (111)
The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. (2000) (110)
Influence of hemoglobin E trait on the severity of Falciparum malaria. (1999) (110)
Helminth infections are associated with protection from malaria-related acute renal failure and jaundice in Thailand. (2001) (109)
Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria (2006) (108)
Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. (2001) (107)
Helminth infections are associated with protection from cerebral malaria and increased nitrogen derivatives concentrations in Thailand. (2002) (106)
Retinal hemorrhage, a common sign of prognostic significance in cerebral malaria. (1983) (105)
Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes (2002) (105)
Artemisinin derivatives in the treatment of falciparum malaria in pregnancy. (1998) (105)
Binding of quinine to plasma proteins in falciparum malaria. (1985) (103)
Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report. (1991) (103)
Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse. (2004) (102)
Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. (2003) (100)
Randomized comparative trial of three monospecific antivenoms for bites by the Malayan pit viper (Calloselasma rhodostoma) in southern Thailand: clinical and laboratory correlations. (1986) (99)
Transmission-Blocking Activities of Quinine, Primaquine, and Artesunate (2006) (99)
Association of Genetic Mutations inPlasmodium vivax dhfr with Resistance to Sulfadoxine-Pyrimethamine: Geographical and Clinical Correlates (2001) (98)
Cardiovascular toxicity and distribution kinetics of intravenous chloroquine. (1986) (98)
CR1 density polymorphism on erythrocytes of falciparum malaria patients in Thailand. (2001) (97)
The bone marrow in human cerebral malaria: parasite sequestration within sinusoids (1987) (97)
CD36 polymorphism is associated with protection from cerebral malaria. (2003) (97)
Population pharmacokinetics of mefloquine in patients with acute falciparum malaria (1999) (95)
Hypoglycaemia and antimalarial drugs: quinidine and release of insulin. (1986) (95)
A national hospital-based survey of snakes responsible for bites in Thailand. (1992) (94)
Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. (1999) (92)
Clinical significance of venom antigen levels in patients envenomed by the Malayan pit viper (Calloselasma rhodostoma). (1986) (91)
Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. (1999) (91)
Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. (2004) (88)
Function of the blood-cerebrospinal fluid barrier in human cerebral malaria: rejection of the permeability hypothesis. (1986) (88)
Quinine and Quinidine: A Comparison of EKG Effects During the Treatment of Malaria (1983) (87)
Serum levels of erythropoietin in acute Plasmodium falciparum malaria. (1996) (87)
A systematic overview of published antimalarial drug trials. (2004) (87)
No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine. (1999) (86)
A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria. (2000) (85)
Human cerebral malaria in Thailand: a clinico-pathological correlation. (1990) (84)
Cytoadherence characteristics of Plasmodium falciparum isolates from Thailand: evidence for chondroitin sulfate a as a cytoadherence receptor. (1996) (83)
Erythrocyte survival in severe falciparum malaria. (1991) (83)
Dyserythropoiesis and ineffective erythropoiesis in Plasmodium vivax malaria (1989) (83)
Neuropathologic toxicity of artemisinin derivatives in a mouse model. (2002) (83)
High-dose primaquine regimens against relapse of Plasmodium vivax malaria. (2008) (83)
VIVAX RELAPSE AFTER FALCIPARUM-MALARIA - REPLY (1988) (80)
Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. (1996) (80)
Overview of clinical studies on artemisinin derivatives in Thailand. (1994) (80)
Arboreal green pit vipers (genus Trimeresurus) of South-East Asia: bites by T. albolabris and T. macrops in Thailand and a review of the literature. (1990) (79)
A study of the factors affecting the metabolic clearance of quinine in malaria (1997) (79)
QUINIDINE IN FALCIPARUM MALARIA (1981) (79)
Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. (2002) (78)
Liver profile changes and complications in jaundiced patients with falciparum malaria. (1994) (78)
Natural human humoral response to salivary gland proteins of Anopheles mosquitoes in Thailand. (2006) (78)
A cross-sectional study of intestinal parasitic infections among schoolchildren in Nan Province, Northern Thailand. (2002) (78)
Single dose phenobarbitone prevents convulsions in cerebral malaria (1988) (78)
Elevated Serum Levels of IL-10 and IFN-γ in Patients with Acute Plasmodium falciparum Malaria (1995) (77)
Evaluation of a real-time polymerase chain reaction assay for the diagnosis of malaria in patients from Thailand. (2005) (77)
Fcgamma receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malaria. (2002) (77)
Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. (2006) (76)
Erythrocyte sequestration and anemia in severe falciparum malaria. Analysis of acute changes in venous hematocrit using a simple mathematical model. (1990) (76)
DECREASED HEMOGLOBIN CONCENTRATIONS, HYPERPARASITEMIA, AND SEVERE MALARIA ARE ASSOCIATED WITH INCREASED PLASMODIUM FALCIPARUM GAMETOCYTE CARRIAGE (2002) (76)
Treatment of vivax malaria on the western border of Thailand. (1999) (74)
In Vitro Antimalarial Activity of Azithromycin, Artesunate, and Quinine in Combination and Correlation with Clinical Outcome (2006) (73)
Src-family kinase signaling modulates the adhesion of Plasmodium falciparum on human microvascular endothelium under flow. (2003) (71)
Plasma Macrophage Colony-Stimulating Factor and P-Selectin Levels in Malaria-Associated Thrombocytopenia (1997) (71)
Serum concentrations of MIP-1 alpha and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria. (1995) (69)
Factors contributing to fatal snake bite in the rural tropics: analysis of 46 cases in Thailand. (1988) (69)
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. (2009) (69)
Evaluation of a new Plasmodium lactate dehydrogenase assay (OptiMAL-IT) for the detection of malaria. (2003) (69)
Therapeutic Responses to Quinine and Clindamycin in Multidrug-Resistant Falciparum Malaria (2000) (69)
Mapping soil-transmitted helminths in Southeast Asia and implications for parasite control. (2003) (68)
Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial. (2010) (68)
Contribution of humoral immunity to the therapeutic response in falciparum malaria. (2001) (67)
Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins. (2007) (67)
Quinine Pharmacokinetic-Pharmacodynamic Relationships in Uncomplicated Falciparum Malaria (2003) (67)
Population Pharmacokinetics of Artesunate and Dihydroartemisinin following Intra-Rectal Dosing of Artesunate in Malaria Patients (2006) (66)
The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy. (2002) (66)
Platelet-induced autoagglutination of Plasmodium falciparum-infected red blood cells and disease severity in Thailand. (2004) (66)
Limited Polymorphism in the Dihydropteroate Synthetase Gene (dhps) of Plasmodium vivax Isolates from Thailand (2005) (66)
Drug resistant malaria, with special reference to Thailand. (1992) (66)
A comparison of the in vivo kinetics of Plasmodium falciparum ring-infected erythrocyte surface antigen-positive and -negative erythrocytes. (2001) (65)
Failure of interferon alfa and tribavirin in rabies encephalitis. (1989) (65)
Bacteriological studies of the venom and mouth cavities of wild Malayan pit vipers (Calloselasma rhodostoma) in southern Thailand. (1990) (64)
Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand. (1998) (64)
Keys to success for a school-based malaria control program in primary schools in Thailand. (2006) (64)
Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects. (1985) (63)
Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria. (2001) (62)
Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. (2003) (62)
Splenic Fc receptor function in host defense and anemia in acute Plasmodium falciparum malaria. (1990) (61)
Meteorological, environmental remote sensing and neural network analysis of the epidemiology of malaria transmission in Thailand. (2006) (61)
Activation of the coagulation cascade in falciparum malaria. (1989) (60)
TREATMENT OF PATIENTS WITH RECRUDESCENT FALCIPARUM MALARIA WITH A SEQUENTIAL COMBINATION OF ARTESUNATE AND MEFLOQUINE (1992) (60)
Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers. (1987) (59)
Involvement of cytokines in the histopathology of cerebral malaria. (1997) (59)
Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria. (1998) (59)
Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand (1992) (59)
Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria. (1994) (59)
Contrasting functions of IgG and IgE antimalarial antibodies in uncomplicated and severe Plasmodium falciparum malaria. (2000) (58)
Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects. (1987) (58)
Longitudinal study of Plasmodium falciparum and Plasmodium vivax in a Karen population in Thailand (2008) (58)
Plasmodium falciparum: effect of anti-malarial drugs on the production and secretion characteristics of histidine-rich protein II. (2002) (57)
Ex-vivo short-term culture and developmental assessment of Plasmodium vivax. (2001) (56)
Pharmacokinetics of three commercial antivenoms in patients envenomed by the Malayan pit viper, Calloselasma rhodostoma, in Thailand. (1990) (56)
Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. (2003) (56)
Efficacy of DB289 in Thai patients with Plasmodium vivax or acute, uncomplicated Plasmodium falciparum infections. (2005) (56)
Chloroquine sensitivity of Plasmodium vivax in Thailand. (1999) (56)
A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand. (1999) (56)
Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum–infected erythrocytes to microvascular endothelial cells under flow (2000) (55)
Association of Genetic Mutations in Plasmodium vivax dhfr with Resistance to Sulfadoxine-Pyrimethamine: Geographical and Clinical Correlates (2002) (55)
Glucose turnover in severe falciparum malaria. (1993) (55)
Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand. (2002) (54)
Pharmacokinetics of Oral Doxycycline during Combination Treatment of Severe Falciparum Malaria (2005) (54)
Quinine pharmacokinetics and toxicity in pregnant and lactating women with falciparum malaria. (1986) (54)
Convulsions in childhood malaria. (1994) (53)
Quinine induces reversible high-tone hearing loss. (1990) (53)
Association of helminth infections with increased gametocyte carriage during mild falciparum malaria in Thailand. (2001) (53)
A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. (1993) (52)
Comparison of Oral Artesunate and Dihydroartemisinin Antimalarial Bioavailabilities in Acute Falciparum Malaria (2002) (52)
Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand. (1999) (51)
Treatment of malarial acute renal failure by hemodialysis. (1999) (51)
Cytoadherence characteristics of Plasmodium falciparum isolates in Thailand using an in vitro human lung endothelial cells model. (2000) (51)
Expression of toll-like receptors on antigen-presenting cells in patients with falciparum malaria. (2008) (51)
In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand. (2004) (50)
Intestinal helminths and malnutrition are independently associated with protection from cerebral malaria in Thailand (2002) (49)
DETECTION OF ORIENTIA TSUTSUGAMUSHI IN CLINICAL SAMPLES BY QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION (2005) (48)
Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand. (1999) (48)
Thrombopoietin in Plasmodium falciparum malaria (2000) (47)
Pulmonary edema in cerebral malaria patients in Thailand. (1998) (47)
Pharmacokinetics of intravenous amodiaquine. (1987) (47)
Association of helminth infection with decreased reticulocyte counts and hemoglobin concentration in Thai falciparum malaria. (2001) (47)
Qualitative and semiquantitative polymerase chain reaction to predict Plasmodium falciparum treatment failure. (1994) (46)
Plasmodium falciparum hyperparasitaemia: use of exchange transfusion in seven patients and a review of the literature. (1990) (46)
The course of anaemia after the treatment of acute, falciparum malaria. (1998) (46)
Haematinic treatment of anaemia increases the risk of Plasmodium vivax malaria in pregnancy. (2003) (45)
Primaquine-tolerant vivax malaria in Thailand. (1997) (45)
A single-nucleotide substitution from C to T at position −1055 in the IL-13 promoter is associated with protection from severe malaria in Thailand (2003) (45)
Increased fluidity and oxidation of malarial lipoproteins: relation with severity and induction of endothelial expression of adhesion molecules (2004) (45)
Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand. (1997) (45)
Mekong malaria. II. Update of malaria, multi-drug resistance and economic development in the Mekong region of Southeast Asia. (2003) (45)
Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. (1994) (44)
Dynamic changes in white blood cell counts in uncomplicated Plasmodium falciparum and P. vivax malaria. (2008) (44)
Adverse Effect of Rifampin on Quinine Efficacy in Uncomplicated Falciparum Malaria (2003) (43)
Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria. (1988) (43)
Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria. (1999) (43)
Significant association between TNF-alpha (TNF) promoter allele (-1031C, -863C, and -857C) and cerebral malaria in Thailand. (2007) (43)
Measurement of serum nitrite/nitrate concentrations using high-performance liquid chromatography. (1998) (43)
Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand. (2001) (42)
Differential Roles of CD36, ICAM‐1, and P‐selectin in Plasmodium falciparum Cytoadherence In Vivo (2007) (42)
Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria. (2005) (42)
Role of Known Molecular Markers of Resistance in the Antimalarial Potency of Piperaquine and Dihydroartemisinin In Vitro (2009) (42)
Recombinant PfEMP1 peptide inhibits and reverses cytoadherence of clinical Plasmodium falciparum isolates in vivo. (2003) (42)
Efficacy and tolerability of a sequential, artesunate suppository plus mefloquine, treatment of severe falciparum malaria. (1995) (42)
Association of hepatomegaly and jaundice with acute renal failure but not with cerebral malaria in severe falciparum malaria in Thailand. (2001) (42)
Randomised trial of mefloquine-tetracycline and quinine-tetracycline for acute uncomplicated falciparum malaria. (1994) (41)
Hypoglycaemia and counterregulatory hormone responses in severe falciparum malaria: treatment with Sandostatin. (1993) (41)
Assessment of the neurotoxicity of oral dihydroartemisinin in mice. (2002) (41)
The future outlook of antimalarial drugs and recent work on the treatment of malaria. (2002) (41)
Quinine pharmacokinetics in cerebral malaria: predicted plasma concentrations after rapid intravenous loading using a two-compartment model. (1988) (41)
THE SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH (2006) (41)
Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria. (1991) (41)
Are Extensive T Cell Epitope Polymorphisms in the Plasmodium falciparum Circumsporozoite Antigen, a Leading Sporozoite Vaccine Candidate, Selected by Immune Pressure?1 (2005) (40)
Independent Evolution of Pyrimethamine Resistance in Plasmodium falciparum Isolates in Melanesia (2007) (40)
Plasmodicidal effect of desferrioxamine B in human vivax or falciparum malaria from Thailand. (1992) (40)
Contemporaneous and Successive Mixed Plasmodium falciparum and Plasmodium vivax Infections Are Associated with Ascaris lumbricoides: An Immunomodulating Effect? (2001) (40)
Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in Thailand. (2006) (40)
Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: two- and three-day regimens. (1996) (39)
Hepatic blood flow and metabolism in severe falciparum malaria: clearance of intravenously administered galactose. (1992) (39)
A comparative clinical trial of sequential treatments of severe malaria with artesunate suppository followed by mefloquine in Thailand. (1997) (39)
Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis (1987) (38)
Antibody‐dependent red cell removal during P. falciparum malaria: the clearance of red cells sensitized with an IgG anti‐D (1989) (38)
Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria. (1997) (38)
Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria. (1991) (38)
Rapid diagnosis of rabies and post-vaccinal encephalitides. (1988) (38)
Glucose Metabolism In Quinine‐Treated Patients With Uncomplicated Falciparum Malaria (1990) (38)
Serum procalcitonin levels in severe Plasmodium falciparum malaria. (1998) (37)
Storage duration and polymerase chain reaction detection of Plasmodium falciparum from blood spots on filter paper. (2003) (37)
An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. (2005) (37)
Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria (2008) (37)
Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria (1996) (37)
Soluble intercellular adhesion molecule-1 (ICAM-1), endothelial leukocyte adhesion molecule-1 (ELAM-1), and tumor necrosis factor receptor (55 kDa TNF-R) in patients with acute Plasmodium falciparum malaria. (1994) (37)
A prospective clinical and bacteriologic study of inguinal buboes in Thai men. (1996) (36)
Minor liver profile dysfunctions in Plasmodium vivax, P. malaria and P. ovale patients and normalization after treatment. (2006) (36)
Emergence and clearance of gametocytes in uncomplicated Plasmodium falciparum malaria. (2006) (36)
Relative levels of IL4 and IFN-gamma in complicated malaria: association with IL4 polymorphism and peripheral parasitemia. (2007) (36)
Polymorphisms of the HLA-B and HLA-DRB1 genes in Thai malaria patients. (2005) (36)
Randomized trial of mefloquine alone and artesunate followed by mefloquine for the treatment of acute uncomplicated falciparum malaria. (1994) (35)
The pharmacokinetics of oral dihydroartemisinin and artesunate in healthy Thai volunteers. (2004) (35)
A potential role of interleukin 18 in severe falciparum malaria. (2004) (35)
IgE deposition in brain microvessels and on parasitized erythrocytes from cerebral malaria patients. (2000) (35)
NEW PURIFIED VERO-CELL VACCINE PREVENTS RABIES IN PATIENTS BITTEN BY RABID ANIMALS (1986) (34)
INTRAVENOUS AMODIAQUINE AND ORAL AMODIAQUINE/ERYTHROMYCIN IN THE TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA (1985) (34)
Risk factors of helminthiases among schoolchildren in southern Thailand. (2003) (34)
New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus Mefloquine (2010) (34)
Complement activation in severe Plasmodium falciparum malaria. (1997) (34)
Decreased serum levels of TGF-beta in patients with acute Plasmodium falciparum malaria. (1995) (34)
Factors contributing to the development of cerebral malaria. II. Endotoxin. (1985) (34)
Evidence against immune haemolysis in falciparum malaria in Thailand (1986) (33)
Therapeutic responses to antibacterial drugs in vivax malaria. (2001) (33)
Complement Activation in SeverePlasmodium falciparumMalaria (1997) (33)
Intestinal sarcocystosis in Thai laborers. (1996) (33)
Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria. (1998) (33)
Treatment of acute, uncomplicated, falciparum malaria with oral dihydroartemisinin. (1996) (33)
Socio-economic and environmental protective/risk factors for severe malaria in Thailand. (2001) (33)
Genetic analysis of Plasmodium falciparum infections on the north-western border of Thailand. (1999) (33)
Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand. (2007) (33)
A comparison of artesunate alone with combined artesunate and quinine in the parenteral treatment of acute falciparum malaria. (2001) (32)
DANGERS OF HIGH-DOSE QUININE AND OVERHYDRATION IN SEVERE MALARIA (1985) (32)
Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand. (2003) (31)
Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand. (2007) (31)
EFFECTIVENESS OF SMS 201-995, A SYNTHETIC, LONG-ACTING SOMATOSTATIN ANALOGUE, IN TREATMENT OF QUININE-INDUCED HYPERINSULINAEMIA (1986) (31)
Big endothelin in patients with complicated Plasmodium falciparum malaria. (1996) (31)
Influence of hemoglobin E trait on the antimalarial effect of artemisinin derivatives. (2000) (30)
Involvement of interleukin-18 in severe Plasmodium falciparum malaria. (2003) (30)
The use of flow cytometry as a diagnostic test for malaria parasites. (2004) (30)
Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine. (1987) (29)
Cytokines associated with pathology in the brain tissue of fatal malaria. (1999) (29)
Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro. (1996) (29)
Changes in the peripheral blood eosinophil count in falciparum malaria. (1991) (29)
Short report: detection of Orientia tsutsugamushi in clinical samples by quantitative real-time polymerase chain reaction. (2005) (29)
Monotherapy with sodium artesunate for uncomplicated falciparum malaria in Thailand: a comparison of 5- and 7-day regimens. (1997) (28)
Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response. (2005) (28)
Intragastric mefloquine is absorbed rapidly in patients with cerebral malaria. (1985) (28)
Elevated serum levels of IL-10 and IFN-gamma in patients with acute Plasmodium falciparum malaria. (1995) (28)
In vitro study of malaria parasite induced disruption of blood-brain barrier. (2005) (28)
Memory T cells protect against Plasmodium vivax infection. (2006) (27)
A correlation between sequestered parasitized erythrocytes in subcutaneous tissue and cerebral malaria. (1995) (27)
Misclassification of drug failure in Plasmodium falciparum clinical trials in southeast Asia. (2009) (27)
Purified Vero cell rabies vaccine and human diploid cell strain vaccine: comparison of neutralizing antibody responses to post-exposure regimens (1986) (27)
FAILURE OF CHLOROQUINE-ERYTHROMYCIN AND CHLOROQUINE-TETRACYCLINE COMBINATIONS IN TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN EASTERN THAILAND (1984) (27)
Plasmodium vivax malaria in Southeast Iran in 1999-2001: establishing the response to chloroquine in vitro and in vivo. (2002) (27)
Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand. (2002) (27)
Hidden Plasmodium falciparum infections. (1999) (27)
An open randomized clinical trial of Artecom vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand. (2002) (26)
Seasonal variation in hyperparasitaemia and gametocyte carriage in patients with Plasmodium falciparum malaria on the Thai-Burmese border. (2004) (26)
Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand. (2008) (26)
Genetic Analysis of the Dihydrofolate Reductase-Thymidylate Synthase Gene from Geographically Diverse Isolates of Plasmodium malariae (2007) (26)
Short report: Hookworm infection is associated with decreased body temperature during mild Plasmodium falciparum malaria. (2001) (26)
Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria. (2007) (26)
The use of the multi-organ-dysfunction score to discriminate different levels of severity in severe and complicated Plasmodium falciparum malaria. (2005) (26)
Clinical trials with halofantrine in acute uncomplicated falciparum malaria in Thailand. (1993) (26)
Red cell quinine concentrations in falciparum malaria. (1983) (26)
Quantitation of cell-derived microparticles in plasma using flow rate based calibration. (2008) (26)
Fatal Plasmodium falciparum malaria after an inadequate response to quinine treatment. (1990) (25)
Suppressive effects of the anti-oxidant N-acetylcysteine on the anti-malarial activity of artesunate. (2007) (25)
Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand. (2001) (25)
Pharmacokinetic investigation on the therapeutic potential of artemotil (beta-arteether) in Thai patients with severe Plasmodium falciparum malaria. (2004) (25)
N-acetylcysteine in severe falciparum malaria in Thailand. (2003) (24)
Suppression of Plasmodium falciparum by serum collected from a case of Plasmodium vivax infection (2008) (24)
Thrombocytopenia in malaria. (1992) (24)
Absence of association between the allele coding methionine at position 29 in the N-terminal domain of ICAM-1 (ICAM-1(Kilifi)) and severe malaria in the northwest of Thailand. (2001) (24)
Down-regulation of tight junction mRNAs in human endothelial cells co-cultured with Plasmodium falciparum-infected erythrocytes. (2006) (24)
Altered expression of human monocyte Fc receptors in Plasmodium falciparum malaria (1984) (23)
Intravenous ibuprofen (IV-ibuprofen) controls fever effectively in adults with acute uncomplicated Plasmodium falciparum malaria but prolongs parasitemia. (2010) (23)
In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance. (2001) (23)
Absence of an interaction between artesunate and atovaquone – proguanil (1999) (23)
Absence of knobs on parasitized red blood cells in a splenectomized patient in fatal falciparum malaria. (2000) (23)
APACHE II scoring for predicting outcome in cerebral malaria. (1995) (23)
Intramuscular loading dose of quinine for falciparum malaria: pharmacokinetics and toxicity. (1986) (23)
Detection of anti-neutrophil cytoplasmic antibodies after acute Plasmodium falciparum malaria (1996) (22)
Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia. (2008) (22)
Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand. (2004) (22)
Risk factors for Plasmodium vivax gametocyte carriage in Thailand. (2004) (22)
Decreased serum levels of TGF-β in patients with acutePlasmodium falciparum malaria (1995) (22)
Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand. (2003) (22)
Effects of α-Thalassemia on Pharmacokinetics of the Antimalarial Agent Artesunate (1998) (21)
A human volunteer challenge model using frozen bacteria of the new epidemic serotype, V. cholerae O139 in Thai volunteers. (2001) (21)
Factors associated with acute renal failure in severe falciparum [corrected] malaria patients. (2010) (20)
Heritability of P. falciparum and P. vivax Malaria in a Karen Population in Thailand (2008) (20)
A comparison of three different dihydroartemisinin formulations for the treatment of acute uncomplicated falciparum malaria in Thailand. (1998) (20)
Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria. (2002) (20)
A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria. (2002) (20)
Molecular markers for chloroquine-resistant Plasmodium falciparum malaria in Thailand and Laos. (2001) (20)
Serum concentrations of granulocyte-colony stimulating factor in complicated Plasmodium falciparum malaria. (2000) (20)
Comparison of Artesunate and Chloroquine Activities against Plasmodium vivax Gametocytes (2004) (20)
Lack of association of -308A/G TNFA promoter and 196R/M TNFR2 polymorphisms with disease severity in Thai adult malaria patients. (2001) (20)
Predictive score of uncomplicated falciparum malaria patients turning to severe malaria. (2007) (20)
A functional polymorphism in the IL1B gene promoter, IL1B -31C>T, is not associated with cerebral malaria in Thailand (2005) (20)
The effects of quinine and artesunate treatment on plasma tumor necrosis factor levels in malaria-infected patients. (1999) (19)
Field Evaluation of a Novel Colorimetric Method—Double-Site Enzyme-Linked Lactate Dehydrogenase Immunodetection Assay—To Determine Drug Susceptibilities of Plasmodium falciparum Clinical Isolates from Northwestern Thailand (2004) (19)
Opisthorchis viverrini: clinical experience with praziquantel in Hospital for Tropical Diseases. (1984) (19)
Significant Association Between TIM1 Promoter Polymorphisms and Protection Against Cerebral Malaria in Thailand (2008) (19)
Quinine and severe falciparum malaria in late pregnancy. (1986) (19)
Cutaneous delayed-type hypersensitivity responsiveness in patients during and after Plasmodium falciparum and Plasmodium vivax infections. (1995) (19)
Cerebral malaria: a new way forward with magnetic resonance imaging (MRI). (2009) (19)
Scoring systems for predicting outcomes of critically ill patients in northeastern Thailand. (1995) (18)
Early treatment failure in severe malaria resulting from abnormally low plasma quinine concentrations. (2006) (18)
Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand. (2003) (18)
Atovaquone and proguanil hydrochloride for treatment of malaria. (1999) (18)
The ICT Malaria Pf: a simple, rapid dipstick test for the diagnosis of Plasmodium falciparum malaria at the Thai-Myanmar border. (1997) (17)
A combination of quinine, quinidine and cinchonine (LA 40221) in the treatment of chloroquine resistant falciparum malaria in Thailand: two double-blind trials. (1989) (17)
The pituitary-thyroid axis in severe falciparum malaria: evidence for depressed thyrotroph and thyroid gland function. (1990) (17)
Prognostic significance of skin and subcutaneous fat sequestration of parasites in severe falciparum malaria. (2000) (17)
Lymphocyte responsiveness to a candidate malaria sporozoite vaccine (R32tet32) of individuals with naturally acquired Plasmodium falciparum malaria. (1988) (17)
Can treatment of P. vivax lead to a unexpected appearance of falciparum malaria? (2001) (17)
Consensus recommendation on the treatment of malaria in Southeast Asia. (1998) (17)
Determination of failure of treatment of plasmodium falciparum infection by using polymerase chain reaction single-strand conformational polymorphism fingerprinting. (1999) (16)
Trichuris trichiura infection is associated with the multiplicity of Plasmodium falciparum infections, in Thailand (2003) (16)
Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives. (2003) (16)
Plasmodium vivax: polymerase chain reaction amplification artifacts limit the suitability of pvgam1 as a genetic marker. (2001) (16)
Research on new antimalarial drugs and the use of drugs in combination at the Bangkok Hospital for Tropical Diseases. (1998) (16)
Pharmacokinetics and Comparative Bioavailability of Artesunate and Mefloquine Administered Separately or as a Fixed Combination Product to Healthy Volunteers and Patients with Uncomplicated Plasmodium falciparum Malaria. (2010) (16)
Relationship between reactive nitrogen intermediates and total immunoglobulin E, soluble CD21 and soluble CD23: comparison between cerebral malaria and nonsevere malaria (2002) (16)
Treatment of acute uncomplicated falciparum malaria with a short course of artesunate followed by mefloquine. (1993) (16)
IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria. (2007) (16)
Use of the multi-organ dysfunction score as a tool to discriminate different levels of severity in uncomplicated Plasmodium falciparum malaria. (2003) (15)
Clinical trial of sequential treatments of moderately severe and severe malaria with dihydroartemisinin suppository followed by mefloquine in Thailand. (2000) (15)
Lack of significant association between rosette formation and parasitized erythrocyte adherence to purified CD36. (1998) (15)
Co-administration of desferrioxamine B with artesunate in malaria: an assessment of safety and tolerance. (1996) (15)
In vitro susceptibility and genetic variations for chloroquine and mefloquine in Plasmodium falciparum isolates from Thai-Myanmar border. (2005) (15)
Lack of Association of the HbE Variant with Protection from Cerebral Malaria in Thailand (2008) (15)
Comparative effects of quinine and quinidine on glucose metabolism in healthy volunteers. (1990) (14)
Artesunate suppositories: an effective treatment for severe falciparum malaria in rural areas. (1997) (14)
Levels of stem cell factor and interleukin-3 in serum in acute Plasmodium falciparum malaria (1997) (14)
Case-control studies on host factors in severe malaria. (2001) (14)
Evaluation of the KAT-Quick Malaria Rapid Test for rapid diagnosis of falciparum malaria in Thailand. (2004) (14)
Attenuation of cytoadherence of Plasmodium falciparum to microvascular endothelium under flow by hemodilution. (2005) (14)
Polymorphisms of CD36 in Thai malaria patients. (2002) (14)
Absence of association between the Fc gamma receptor IIIA-176F/V polymorphism and the severity of malaria in Thai. (2002) (14)
The course of anaemia after the treatment of acute, falciparum malaria (1998) (14)
Effects of alpha-thalassemia on pharmacokinetics of the antimalarial agent artesunate. (1998) (14)
Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in Plasmodium falciparum infected adults from Thailand (2011) (14)
An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria. (2005) (13)
Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate. (2005) (13)
Hepatic metabolism in severe falciparum malaria: caffeine clearance study. (1994) (13)
Effect of oral contraceptive steroids on the clinical course of malaria infection and on the pharmacokinetics of mefloquine in Thai women. (1988) (13)
Intrathecal immunoglobulin synthesis in cerebral malaria. (1987) (13)
Drug studies in developing countries. (2001) (13)
Editorial: Maternal malaria: time for action (2003) (13)
Analysis of circumsporozoite protein-specific immune responses following recent infection with Plasmodium vivax. (2004) (13)
The metabolic response to rapid intravenous glucose injection in acute falciparum malaria. (1991) (13)
Seasonal fluctuations in the carriage of Plasmodium vivax gametocytes in Thailand (2004) (12)
Identification of human malaria parasites and detection of mixed infection in Thai patients by nested PCR. (2004) (12)
Peripheral gangrene in patients with severe falciparum malaria: report of 3 cases. (2006) (12)
Application of yeast enolase as antigen for immunodiagnosis of malaria. (2000) (12)
IgE elevation and anti-plasmodium falciparum IgE antibodies: association of high level with malaria resistance. (2001) (11)
Reduction of parasite levels in patients with uncomplicated malaria by treatment with HE2000. (2007) (11)
Sensitive and Inexpensive Molecular Test for Falcipa- rum Malaria: Detecting Plasmodium falciparum DNA Directly from Heat-Treated Blood by Loop-Mediated (2006) (11)
Differences in genetic population structures of Plasmodium falciparum isolates from patients along Thai-Myanmar border with severe or uncomplicated malaria (2008) (11)
Evaluation of a newly developed dipstick test for the rapid diagnosis of scrub typhus in febrile patients. (2001) (11)
Pharmacokinetics of proguanil in malaria patients treated with proguanil plus atovaquone. (1996) (11)
A clinical trial of combination of artesunate and mefloquine in the treatment of acute uncomplicated falciparum malaria: a short and practical regimen. (1998) (10)
Soluble vascular cell adhesion molecule 1 is elevated in patients with Plasmodium falciparum malaria. (1994) (10)
Food- and water-borne parasitic zoonoses in the 21st century. (2001) (10)
Dyspepsia in acute falciparum malaria: a clinico-pathological correlation. (1992) (10)
Lack of association between interleukin-10 gene promoter polymorphism, -1082G/A, and severe malaria in Thailand. (2002) (10)
Early antibody responses to rabies post-exposure vaccine regimens. (1987) (10)
Antibody response to suckling mouse brain rabies vaccines for post exposure treatment. (1987) (10)
A survey of the Th2R and Th3R allelic variants in the circumsporozoite protein gene of P. falciparum parasites from western Thailand. (2004) (10)
The epidemiology of patients with severe malaria who died at the Hospital for Tropical Diseases, 1991-2004. (2005) (10)
Rediscovery and redefinition of Malcolm Smith's Trimeresurus kanburiensis in Thailand, with a report of envenoming. (1992) (9)
Antipyretic efficacy of indomethacin and acetaminophen in uncomplicated falciparum malaria. (1994) (9)
Tolerability of ivermectin in gnathostomiasis. (2005) (9)
A study of anemia in pregnant women with Plasmodium falciparum at district hospitals in Vientiane, Lao PDR. (2000) (9)
Treatment of chloroquine-resistant falciparum malaria with a combination of quinine, quinidine and cinchonine (LA40221) in adults by oral and intravenous administration. (1987) (9)
Hyponatraemia and hypokalaemia in adults with uncomplicated malaria in Thailand (2008) (9)
Frequency of early rising parasitemia in falciparum malaria treated with artemisinin derivatives. (2001) (9)
Disposition of proguanil in Thai patients with uncomplicated falciparum malaria. (1997) (8)
Monocyte chemoattractant protein 1 (MCP-1) gene polymorphism is not associated with severe and cerebral malaria in Thailand. (2006) (8)
Association of splenomegaly with cerebral malaria and decreased concentrations of reactive nitrogen intermediates in Thailand. (2001) (8)
Transient Lesion in the Splenium of the Corpus Callosum in Acute Uncomplicated Falciparum Malaria (2014) (8)
Blood stage Plasmodium falciparum antigens induce immunoglobulin class switching in human enriched B cell culture. (2009) (8)
Efficacy of ivermectin treatment of cutaneous gnathostomiasis evaluated by placebo-controlled trial. (2006) (8)
Plasma concentrations and toxicity of chloroquine after slow intravenous infusion in patients with falciparum malaria. (1987) (8)
Guideline in management of severe malaria. (2000) (8)
Helicobacter pylori prevalence in northeastern Thailand. (1993) (7)
Hematopoietic features and apoptosis in the bone marrow of severe Plasmodium falciparum-infected patients: preliminary study. (2005) (7)
Serum laminin in malaria. (1994) (7)
FACTORS ASSOCIATED WITH ACUTE RENAL FAILURE IN SEVERE FALCIPARUM MALARIA PATIENTS (2010) (7)
The Asian Center of International Parasite Control (ACIPAC): five years of achievement. V. Evaluation of the ACIPAC project. (2005) (7)
Rapid Detection of Dengue Viral RNA by Nucleic Acid Sequence-Based Amplification (NASBA) (2002) (7)
Mepacrine accumulation during treatment of chloroquine-resistant falciparum malaria. (1988) (7)
Inverse relationship between the number of fertilized Ascaris eggs excreted and fever, in patients co-infected with Plasmodium vivax and Ascaris lumbricoides. (2005) (7)
Serum laminin and basic fibroblast growth factor concentrations in patients with complicatedPlasmodium falciparum malaria (1996) (6)
Circulating L-selectin is elevated in patients with Plasmodium falciparum malaria. (1995) (6)
Gastric emptying in acute uncomplicated falciparum malaria. (1995) (6)
Encephalitis, not cerebral malaria, is likely cause of coma with negative blood smears. (1992) (6)
Is there any artemisinin resistance in falciparum malaria? (2000) (6)
Low dose tinidazole in the treatment of amoebic liver abscess. (1985) (6)
Management of malaria in Thailand. (2002) (6)
Chemotherapy of Cerebral Malaria (1997) (6)
Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border. (2007) (6)
Chlorproguanil-dapsone for malaria in Africa (2004) (6)
Pustular eruption in a malaria patient treated with chloroquine. (1998) (6)
Circulating receptors implicated in the cyto-adherence occurring in severe Plasmodium falciparum malaria in Thailand. (1999) (5)
Health Status: Malaria, Anemia and Intestinal Parasitic Infections on the Thai-Myanmar Border (2005) (5)
Monitoring of Plasmodium vivax sensitivity to chloroquine in vitro in Thailand. (2003) (5)
Clinical presentation of childhood malaria in Savannakhet province, Lao PDR. (2000) (5)
The Asian center of international parasite control (ACIPAC): five years of achievement. I. Introduction. (2005) (5)
Overview: pathophysiology and management of cerebral malaria. (1992) (5)
Strong linkage disequilibrium of a HbE variant with the (AT)9(T)5 repeat in the BP1 binding site upstream of the β-globin gene in the Thai population (2005) (5)
The rational use of qinghaosu and its derivatives: what is the future of new compounds? (1998) (5)
The malaria cauldron of Southeast Asia: conflicting strategies of contiguous nation states. (2000) (5)
Molecular Characterization of Hereditary Persistence of Fetal Hemoglobin in the Karen People of Thailand (2003) (4)
THE CLINICAL USE OF ARTEMISININ AND ITS DERIVATIVES IN THE TREATMENT OF MALARIA (2002) (4)
Gender differences in the prevalences of human infection with intestinal helminths on the Thai–Burmese border (2003) (4)
Application of real-time polymerase chain reaction (PCR) analysis for detection and discrimination of malaria parasite species in Thai patients. (2004) (4)
Prostaglandin spectrum in falciparum malaria patients (2002) (4)
Slow-release quinidine in the treatment of chloroquine resistant falciparum malaria: a double-blind trial. (1987) (4)
DEXAMETHASONE IN CEREBRAL MALARIA - REPLY (1982) (3)
Travelers' malaria among foreigners at the Hospital for Tropical Diseases, Bangkok, Thailand - a 6-year review (2000-2005). (2006) (3)
Lack of association between CSF nitrate and sera nitrate in falciparum malaria infection. (2001) (3)
Melioidotic otitis media. (1994) (3)
Glucose-6-phosphate dehydrogenase deficiency in Thailand: the influence on the clinical presentation of malaria in male adult patients. (1988) (3)
Cerebrospinal fluid lactate in P. falciparum malaria: measurement by chemical shift imaging at 3 Tesla (2007) (3)
Malaria and amphetamine ‘horse tablets’ in Thailand (2003) (3)
The treatment of severe falciparum malaria (1985) (3)
A PILOT FIELD TRIAL OF AN IN VITRO DRUG SUSCEPTIBILITY TEST USING THE ANAEROPACK® MALARIA CULTURE SYSTEM ON THE THAI-MYANMAR BORDER (2004) (3)
TREATMENT OF FALCIPARUM-MALARIA (1987) (3)
THE DISPOSITION OF A SINGLE INFUSION OF CHLOROQUINE IN PATIENTS WITH VIVAX MALARIA (1986) (2)
Predictive role of laboratory and clinical treatment response parameters and glucose-6-phosphate dehydrogenase status in the therapy of falciparum malaria. (2002) (2)
The genotypes of GYPA and GYPB carrying the MNSs antigens are not associated with cerebral malaria (2007) (2)
Predicting mortality in patients with malarial acute renal failure (2000) (2)
Association of intestinal helminths with decreased liver size and sCD23 concentration during falciparum malaria. (2004) (2)
Paroxysm serum from a case of Plasmodium vivax malaria inhibits the maturation of P. falciparum schizonts in vitro (2003) (2)
Efficacy of DB289 in Thai Patients (2005) (2)
Serological Evaluation of Malaria Patients in Thailand, with Particular Reference to the Reactivity against a 47KD Antigenic Polypeptide of Plasmodium falciparum(Abstracts from the Malaria Workshop) (1997) (2)
Maternal malaria: time for action [editorial] (2003) (2)
Field Evaluation of a Novel Colorimetric Method—Double-Site Enzyme-Linked Lactate Dehydrogenase Immunodetection Assay—To Determine Drug Susceptibilities of Plasmodium falciparum Clinical Isolates from Northwestern Thailand (2004) (2)
Absorption kinetics of mefloquine in pregnant patients with chloroquine-resistant falciparum malaria (1990) (2)
Characterization of synthetic peptides of a plasmodium falciparum specific enzyme of the glycolytic pathway (1998) (1)
Migrating Ascaris during cerebral malaria: potential risk of airway obstruction. (1993) (1)
Malaria in southern Thailand: relationship between parasitaemia and disease. (2001) (1)
Phase I Clinical Trial to Evaluate the Safety and Tolerability of Oral SN-1 Extract Formulation in Healthy Thai Volunteers (2004) (1)
Receptor 9-Dependent Pathway Murine Dendritic Cells through a Toll-Like Human Plasmacytoid Dendritic Cells and Malaria Blood Stage Parasites Activate (2004) (1)
Polymorphisms of HLA-DRB1 and TNF α promorter region in adult patients with severe malaria in Thailand (2000) (1)
Clinical trial of halofantrine with modified doses for treatment of malaria in the hospital for tropical diseases. (2001) (1)
Clinical experience with artemisinin derivative containing combinations (ADCC) in Thailand (2001) (1)
VTVAX RELAPSE AFTER FALCIPARUM MALARIA (1988) (1)
The mechanisms of parasite clearance after antimalarial treatment of plamodium falciparum malaria Chotivanich, (1)
Pyronaridine (1996) (1)
CLINICAL MALARIA AND TREATMENT OF MULTIDRUG RESISTANCE FALCIPARUM IN THAILAND (1999) (1)
INCIDENCE OF FILARIASIS AS A CO-INFECTION IN MALARIA PATIENTS COMING FROM THAI-MYANMAR BORDER BETWEEN 1995-1997 (1998) (1)
Six-years monitoring the efficacy of the combination of artesunate and mefloquine for the treatment of uncomplicated falciparum malaria. (2003) (1)
Genetic variants of beta-globin gene in Thai malaria patients. (2003) (1)
A definitive look at tropical diseases Gordon C Cook Alimuddin I (2003) (1)
Liver function tests and clinical severity of dengue infection in adult patients (2003) (1)
THE SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH (2019) (1)
Serological evaluation of malaria patients in Thailand: antibody response against electrophoresed antigenic polypeptides of Plasmodium falciparum. (1998) (1)
Circulating cell-derived microparticles in malaria patients (2006) (0)
New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparumin Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus Mefloquine (2010) (0)
P-Selectin Interaction Under Flow Conditions -Infected Erythrocyte and Plasmodium falciparum Characterization of (2010) (0)
Increased serum concentrations of the carboxy-terminal-cross-linked telopeptide of collagen type I in patients with acute Plasmodium falciparum malaria. (1996) (0)
Comparison of Pharmacokinetics-Pharmacodynamics of Artemisinin Derivatives in Healthy Normal Volunteers and Uncomplicated Malaria Patients (2000) (0)
Pustular eruption in a malaria patient treated with chloroquine. (1998) (0)
Rapiddiagnosis ofrabies andpost-vaccinal encephalitides (1988) (0)
Mauricio Goihman‐Yahr, MD, PhD, Editor (1997) (0)
Title Clinical Malaria and Treatment of Multidrug Resistance Falciparum inThailand (2019) (0)
Immune Pressure? Sporozoite Vaccine Candidate, Selected by Circumsporozoite Antigen, a Leading Plasmodium falciparum in the Are Extensive T Cell Epitope Polymorphisms (2005) (0)
receptors in Plasmodium falciparum malaria. Altered expression of human monocyte Fc (2013) (0)
SpecialIssue Medical Treatment of Malaria in Thailand (2005) (0)
Management of malaria with acute renal failure (1999) (0)
Antimalarial chemotherapy: mechanisms of action, resistance, and new directions in drug discovery, Phillip J Rosenthal (Ed.). Humana Press (2001), US$135, 396 pp, ISBN: 0896036707 (2001) (0)
In vitro blood brain barrier study of cerebral malaria infection (2005) (0)
Lack of interferon induction in man by two rabies tissue culture vaccines. (1985) (0)
Modification of Lipoprotein in Acute Falciparum Malaria Infection. (2003) (0)
Cell-Mediated Immunity to plasmodium VIVAX infection (2016) (0)
ANEMIA AND P-FALCIPARUM MALARIA (1985) (0)
POLYCLONAL ANTI-TUMOR NECROSIS FACTOR- (cid:97) Fab USED AS AN ANCILLARY TREATMENT FOR SEVERE MALARIA (1999) (0)
Pharmacokinetics ofprimaquine inman II.Comparison ofacutevschronic dosage inThaisubjects (1985) (0)
ClinicalMalariaand Treatment of MultidrugResistance Falciparumin Thailand (1998) (0)
Hemolytic Anemia and Thromobocytopenia Associated with Ischemic Brain Lesions in Patients with Acute Uncomplicated Plasmodium Falciparum Malaria. (2006) (0)
RApid immunochRomAtogRAphic test foR glucose-6-phosphAte dehydRogenAse deficiency (2019) (0)
CLINICAL EXPERIENCE WITH CURDLAN SULFATE IN PLASMODIUM FALCIPURUM MALARIA (2001) (0)
Effects of mefloquine usage on genetic polymorphism of Plasmodium falciparum in Thai-Myanmarese border. (2003) (0)
Erratum: Field evaluation of a novel colorimetric method - Double-site enzyme-linked lactate dehydrogenase immunodetection assay - To determine drug susceptibilities of Plasmodium falciparum clinical isolates from Northwestern Thailand (Antimicrobial Agents and Chemotherapy (2004) 48, 4 (1426-1429) (2004) (0)
HRP2-BASED DRUG SENSITIVITY ASSAYS: CURRENT DATA, FUTURE PERSPECTIVES (2003) (0)
Liver of cerebral malaria patient was void of retinol store: a first observation on vitamin a-storing cells from autopsy specimen (2016) (0)
The Relationship between Splenomegaly and Severity of Falciparum Malaria (1990) (0)
Breathing in the tropics made easy JN Pande 2000 (2000) (0)
ARTESUNATE-MEFLOQUINE IN THE TREATMENT OF ACUTE UNCOMPLICATED FALCIPARUM MALARIA (2006) (0)
The occurence of point mutations in the dihydrofolate reductase-thymidylate synthase (DHFR) gene in Thai isolates of Plasmodium falciparum. (1998) (0)
Perspective Cerebral Malaria: A New Way Forward with Magnetic Resonance Imaging (MRI) (2009) (0)
Different Plasma Levels of Circulating Cell Adhesion Molecules in Falciparum Malaria Patients According to Disease Severity(Abstracts from the Malaria Workshop) (1997) (0)
Disposition of artesunate and mefloquine after administration as FDC to adult Thai healthy volunteers and uncomplicated falciparum malaria patients. (2008) (0)
Food- and water-borne parasitic zoonoses in the 21st century. (2001) (0)
Research on New Antimalarial Drugs in the Bangkok Hospital for Tropical Diseases(Abstracts from the Malaria Workshop) (1997) (0)
RANDOMIZED TRIAL OF THREE-DAY TREATMENT WITH ARTESUNATE COMBINED WITH A STANDARD DOSE OF MEFLOQUINE DIVIDED OVER EITHER TWO OR THREE DAYS , FOR ACUTE , UNCOMPLICATED FALCIPARUM MALARIA (2006) (0)
Mechanisms of Disease (1996) (0)
Lack of association of interleukin-10 gene promother polymorphism, -1082g/a, with severe malaria in Thailand (2016) (0)
Currently , at the TOLERABILITY OF IVERMECTIN IN GNATHOSTOMIASIS (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Sornchai Looareesuwan?

Sornchai Looareesuwan is affiliated with the following schools: